Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Carson

Showing results (111-120 of 248) with videos related to

Pageof 25
Sort By:
Gynecologic Oncology|March 27, 2001
Phase I trial of ifosfamide and 24-h infusional paclitaxel in pelvic malignancies: a Gynecologic Oncology Group studyM Markman, D Spriggs, R A Burger, et al.
Gynecologic Oncology|August 1, 1990
Surgical intervention following multimodality therapy for advanced cervical cancerR A Potish, L B Twiggs, K A Prem, et al.
Infectious Diseases in Obstetrics and Gynecology|January 1, 1994
Infectious morbidity after radical vulvectomyS A Elg, L F Carson, D C Brooker, et al.
International Journal of Antimicrobial Agents|March 14, 2013
Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrolNatalie A Thomsen, Katherine A Hammer, Thomas V Riley, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1992
Ciprofloxacin and Clostridium difficile-associated diarrhoeaC L Golledge, C F Carson, G L O'Neill, et al.
Gynecologic Oncology|February 22, 2005
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group studyGregory Sutton, James Kauderer, Linda F Carson, et al.
Gynecologic Oncology|August 21, 2007
Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancerJustin C Chura, Kelin Van Iseghem, Levi S Downs, et al.
The Journal of Sports Medicine and Physical Fitness|September 12, 2015
The mediating role of mental toughness in sportA R Nicholls, J L Perry, L Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, P J DiSaia, et al.
American Journal of Obstetrics and Gynecology|October 1, 1986
Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndromeL F Carson, L B Twiggs, M Fukushima, et al.
Pageof 25

Showing results (111-120 of 248) with videos related to

Sort By:
Pageof 25
Gynecologic Oncology|March 27, 2001
Phase I trial of ifosfamide and 24-h infusional paclitaxel in pelvic malignancies: a Gynecologic Oncology Group studyM Markman, D Spriggs, R A Burger, et al.
Gynecologic Oncology|August 1, 1990
Surgical intervention following multimodality therapy for advanced cervical cancerR A Potish, L B Twiggs, K A Prem, et al.
Infectious Diseases in Obstetrics and Gynecology|January 1, 1994
Infectious morbidity after radical vulvectomyS A Elg, L F Carson, D C Brooker, et al.
International Journal of Antimicrobial Agents|March 14, 2013
Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrolNatalie A Thomsen, Katherine A Hammer, Thomas V Riley, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1992
Ciprofloxacin and Clostridium difficile-associated diarrhoeaC L Golledge, C F Carson, G L O'Neill, et al.
Gynecologic Oncology|February 22, 2005
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group studyGregory Sutton, James Kauderer, Linda F Carson, et al.
Gynecologic Oncology|August 21, 2007
Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancerJustin C Chura, Kelin Van Iseghem, Levi S Downs, et al.
The Journal of Sports Medicine and Physical Fitness|September 12, 2015
The mediating role of mental toughness in sportA R Nicholls, J L Perry, L Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, P J DiSaia, et al.
American Journal of Obstetrics and Gynecology|October 1, 1986
Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndromeL F Carson, L B Twiggs, M Fukushima, et al.
Pageof 25